Joseph Redding

Mr. Joseph Redding

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
CCCaleb Cummings
Caleb Cummings
JRJoseph Redding
Joseph Redding
CCChloe Chose
Chloe Chose
STSarah C Tepper
Sarah C Tepper
DJDavid M. Joyce
David M. Joyce
ALAlexander Lazarides
Alexander Lazarides
Background: The Birmingham Atypical Cartilage Tumor Imaging Protocol (BACTIP) addresses referral triage, whereas the Radiological Aggressiveness Score (RAS) estimates resection-grade histology. We evaluated their sequential application in a selected tertiary-center cohort. Methods: This retrospective study included 99 patients during 2001–2025, combining consecutive eligible surgical chondrosarcomas with a nonconsecutive enchondroma sample. Groups comprised lesions outside BACTIP referral categories, referral-category lesions with RAS < 4, and referral-category lesions with RAS ≥ 4. Diagnostic performance for resection-grade disease (grade 2, grade 3, or dedifferentiated chondrosarcoma) and exploratory, unadjusted oncologic outcomes were assessed. Results: All 47 resection-grade tumors met BACTIP referral criteria (sensitivity 100%; 95% CI, 92.4–100%). Requiring RAS ≥ 4 increased whole-cohort specificity from 69.2% to 94.2% and reduced sensitivity to 91.5% (95% CI, 80.1–96.6%). RAS positivity alone and sequential classification identified identical patients. Four grade 2 tumors were RAS-negative despite BACTIP category 3 classification, and grade 2 sensitivity was 78.9% (15/19). Excluding dedifferentiated tumors, sensitivity was 83.3% (20/24). Oncologic events were concentrated in the referral/RAS-positive group, and global log-rank comparisons were significant for all three endpoints (p < 0.001). Conclusions: BACTIP may structure referral assessment, while RAS may further characterize imaging aggressiveness in lesions meeting referral criteria. The four RAS-negative grade 2 tumors underscore the importance of maintaining specialist referral when BACTIP referral criteria are met, even when RAS suggests lower imaging aggressiveness. Neither tool replaces clinical assessment, histopathological correlation, or multidisciplinary review. This selected cohort does not establish safe nonreferral, independent prognostic value, or improved management or outcomes. Prospective validation in the intended referral population is required.

15 July 2026 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
CCCaleb Cummings
Caleb Cummings
JRJoseph Redding
Joseph Redding
CCChloe Chose
Chloe Chose
STSarah C. Tepper
Sarah C. Tepper
DJDavid M. Joyce
David M. Joyce
ALAlexander Lazarides
Alexander Lazarides
Background: Dedifferentiated chondrosarcoma is the most aggressive subtype of chondrosarcoma; however, imaging features that independently distinguish it from other subtypes remain unclear. The purpose of this study was to identify independent imaging predictors of long bone dedifferentiated chondrosarcoma to signal for expedited biopsy and treatment. Methods: This retrospective study incorporated consecutive patients undergoing resection at a tertiary center for primary intramedullary long bone chondrosarcoma between February 2001 and January 2024. Inclusion required preoperative MRI and postoperative pathological confirmation. Seven imaging features were analyzed. Multivariate regression investigated independent predictors of dedifferentiated versus non-dedifferentiated chondrosarcoma. Results: Sixty-seven patients were included. Of these, 23 (34%) patients presented with dedifferentiated chondrosarcoma, while 43 (64%) had conventional chondrosarcoma (21 grade 1, 18 grade 2, 4 grade 3) and one (1.5%) had grade 3 mesenchymal chondrosarcoma. On multivariate analysis, bone marrow edema was the only independent predictor of dedifferentiated status ( p = 0.0091). This association persisted after controlling for age, sex, and tumor size ( p = 0.0057). Bone marrow edema achieved a sensitivity and specificity of 87% and 68%, respectively, and the greatest area under the ROC curve among individual imaging features (AUC = 0.78, p = 0.0027), while the overall combined model achieved even greater discrimination (AUC = 0.87, p < 0.001). Conclusions: Marrow edema was the only imaging feature that independently predicted dedifferentiated chondrosarcoma in multivariable analysis. Although incorporation of additional imaging findings provides the highest overall diagnostic accuracy, marrow edema alone demonstrates high sensitivity and is a readily identifiable marker that may prompt expedited biopsy when identified on routine preoperative MRI.